JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
HRTX Financials - Heron Therapeutics, Inc. /de/ Income & Cash Flow | Ledgeburg
HRTX - Heron Therapeutics, Inc. /de/
USD | NASDAQ | Healthcare
Summary
Summary HRTX Stock
Financials
Financials HRTX Stock
Loading...
Loading...
Income Statement
Income Statement HRTX Stock
Balance Sheet
Balance Sheet HRTX Stock
Cash Flow Statement
Cash Flow Statement HRTX Stock
Loading...
Loading...
Home
Stocks
Heron Therapeutics, Inc. /de/ (HRTX)
Financials
Financials of HRTX
Loading...
Loading...
Loading...
Loading...
Revenue
$154.904M
Operating Income
$-2.538M
Net Income
$-20.195M
Share Count (Basic)
166.707M
Operating Cash Flow
$-27.591M
Free Cash Flow
$-27.908M
Cash And Short-Term Equivalents
$28.647M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
50M
100M
150M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
10M
20M
30M
40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-200M
-150M
-100M
-50M
0
Annual
Quarterly
Margins
Gross
Operating
Net
-300%
-200%
-100%
0%
100%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-15M
-10M
-5M
0
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-50%
0%
50%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26